Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy

Journal of Dermatological Treatment

Volumn 14, Issue 1, 2003, Pages 8-13

  Camarasa, Jose M ^a   Ortonne, J P ^b   Dubertret, L ^c  

^a HOSPITAL DEL MAR   (Spain)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Betamethasone dipropionate; Calcitriol; Efficacy; Psoriasis; Remission; Topical

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCITRIOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OINTMENT; PATIENT; PHYSICIAN; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PROSPECTIVE STUDIES; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037258003     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630305545     Document Type: Article

References (12)

1. Hosomi J, Hosoi J, Abe E et al. Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology (1983) 113: 1950-7.
2. Smith EL, Walworth NC, Holick MF. Effect of 1 alpha. 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol (1986) 86: 709-14.
3. Langner A, Verjans H, Stapor V. 1a25-dihydroxyvitamin D3 (calcitriol) ointment in psoriasis. J Dermatol Treat (1992) 3: 177-80.
4. Hutchinson PE, Marks R, White J. The efficacy, safety and tolerance of topical calcitriol 3 mg/g ointment in the treatment of plaque psoriasis: a comparison with shortcontact dithranol. Dermatology (2000) 201: 139-45.
5. Ring J, Kowalzick L, Christophers E et al. Comparison of combined calcitriol 3 mg/g ointment and UV-B phototherapy with vehicle ointment and UV-B phototherapy in the treatment of plaque psoriasis. Br J Dermatol (2001; in press).
6. Langner A, Ashton P, van de Kerkhof PC et al. A longterm multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol (1996) 135: 385-9.
7. Fredriksson T, Lassus A, Salde L. Reproducibility of clinical trials of topical glucocorticosteroids. Int J Dermatol (1983) 22: 536-9.
8. Guilhou J. The therapeutic effects of vitamin D3 and its analogues in psoriasis. Exp Opin Investig Drugs (1998) 7: 77-84.
9. Federman DG, Froelich CW. Topical psoriasis therapy. Am Fam Physician (1999) 59: 957-62.
10. Berth-Jones J. The emergence of vitamin D as first-line treatment for psoriasis. J Dermatol Treat (1998) 9: S13-18.
11. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol (1999) 41: 51-9.
12. Greaves MW. Topical corticosteroids. J Dermatol Treat (1997) 8: 35-6.